EMJ Podcast: Insights For Healthcare Professionals

This fascinating podcast delves into alternative treatment for non-melanoma skin cancer using Rhenium-SCT; a painless, non-invasive, single-session therapy. Our host is joined by two experts in the nuclear medicine field who work together with dermatologists in the treatment of non-melanoma skin cancer (NMSC) patients: Joe Cardaci, Diagnostic Nuclear Imaging, Hollywood Private Hospital, Nedlands, Australia, and Siddhartha Baxi, Radiation Oncologist and Regional Medical Director, GenesisCare Gold Coast, Tugun, Australia.

This podcast was fully funded and supported by OncoBeta.

This week, Adam Fox, Consultant Paediatric Allergist at Guy's and St Thomas' Hospitals, London, UK and Chair of the UK National Allergy Strategy Group joined our Editor, Evgenia Koutsouki, to talk all things allergy. In this episode, the pair discuss Dr Fox’s career path, which led him to setting up a specialised allergy clinic. A range of pertinent topics are discussed, including the effect of a cleaner lifestyle on our susceptibility to allergies, the evolution of food allergy, and a fascinating insight into the initial concerns surrounding COVID-19 vaccine rollout.  

Jonathan hosts his old friend and former colleague, Keith Hopcroft, who now works as a general practitioner (GP) in Essex, UK. Together, they discuss the role of the GP in the modern world, and changes to continuity of care. The pair also analyse the many myths surrounding male health, and the benefits and pitfalls of using artificial intelligence in medicine.  

This EMJ podcast explores the vital topic of low-density lipoprotein cholesterol (LDL-C) management in relation to the treatment and prevention of atherosclerotic cardiovascular disease. Our host, George Cooper, is joined by Michal Vrablík, First Faculty of Medicine, Charles University, Prague, Czech Republic. Vrablík provides a basic overview of LDL-C, how it might lead to atherosclerotic cardiovascular disease, and how this can ultimately cause a myocardial infarction. Vrablík covers current treatments for patients with high LDL-C, including statins, ezetimibe, and monoclonal antibodies that inhibit proprotein convertase subtilisin/kexin Type 9. Disclaimer: This independent medical education activity is provided by EMJ, and was supported by independent funding from Novartis Pharma AG, who have had no input into the content.  This educational activity is intended for an audience of non-US healthcare professionals. These materials may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities.

This week, Jonathan spoke with Uwe Gudat, Chief Medical Officer, Aretaeus sàrl, Geneva, Switzerland. Together, they discussed a wide range of topics, encompassing non-compliance in patients with Type 2 diabetes, patient education, and biosimilars. The pair explored statistical literacy for healthcare professionals and evidence-based medicine.

Please check out these links for further information on the topics discussed:

https://www.aretaeus.ch/

https://www.drugsafetymedicine.com/

This podcast explores with guest speaker Dr Richard Dilon the potential prognostic value of measurable residual disease (MRD) determination in the treatment and risk assessment of patients with acute myeloid leukaemia (AML).

This podcast focuses on the latest evidence supporting the use of ultrasound in diagnosis within rheumatology with a special focus on rheumatoid arthritis. The speakers consider the evidence for the use of ultrasound to diagnose rheumatoid arthritis and provide perspectives on the challenges stemming from the lack of images and how ultrasound might address them. Sackier and Moller delve into the potential impact of ultrasound on the timing of diagnosis and treatment, and whether it is more effective at ruling out a diagnosis of rheumatoid arthritis than standard methods.

This week, Jonathan spoke with David Hildick-Smith, Professor of Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre, Brighton and Sussex University Hospitals, UK. The pair discussed all things cardiology, with a key focus on interventional procedures and even took a look into David’s creative past. Pertinent topics discussed include the link between migraines and patent foramen ovale and the surge in adverse cardiac events in young athletes, for which David provides his expert perspective.

Join Evgenia Koutsouki, editor of the EMJ family of journals, for this special episode of the EMG-Health Podcast as she looks back at some of the most interesting and memorable moments from the last three months. Jumping into the notable conversation that we have had, this episode provides key insights from this quarter as well as some exciting news of our own! 

This week, we discuss highlights from the International Liver Transplant Society (ILTS) Annual Meeting 2022 in Istanbul, as well as insights into the managment of patients after HBV-related liver transplantation.

This content was sponsored by a medical educational grant from Biotest AG. The views and discussion might not represent the position or endorsement of Biotest AG.